Skip to main content
Figure 3 | BMC Pulmonary Medicine

Figure 3

From: Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

Figure 3

Kaplan-Meier curves showing the observed LuTx-free (A) and observed overall (B) survival from initiation of continuous intravenous iloprost. Patients at risk n = 50, n = 16, n = 10, n = 6, n = 5, n = 5, n = 3 at BL-ilo, 12, 24, 36, 48, 60 and 72 months after initiation of iloprost therapy (observed survival). |: censored patients.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us